Free Radicals and the Pathogenesis of Type 1 Diabetes
β-Cell Cytokine-Mediated Free Radical Generation Via Cyclooxygenase-2
- From the Free Radical Biology & Aging Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma
- Address correspondence and reprint requests to Tahereh Tabatabaie, 825 N.E. 13th St., Oklahoma City, OK 73104. E-mail: tahereh-tabatabaie{at}omrf.ouhsc.edu
Abstract
Free radical formation evoked by proinflammatory cytokines has been suggested to be involved in the destruction of β-cells in the course of type 1 diabetes development. However, there is no direct evidence to support this hypothesis. In this study, we used electron paramagnetic resonance spectroscopy in conjunction with spin-trapping methodology to directly determine whether cytokines give rise to free radical formation in the islets. Our results demonstrate that direct, in vivo administration of tumor necrosis factor-α (1,000 units), interleukin-1β (1,000 units), and interferon-γ (2,000 units) into the rat pancreas through a bile duct cannula leads to the formation of lipid-derived free radicals in this tissue. These free radicals most likely are generated by the β-cells because previous depletion of these cells by streptozotocin abolished the cytokine-induced free radical formation. Furthermore, macrophage depletion was found to decrease the production of free radicals. Inhibition of the enzyme inducible cyclooxygenase (COX-2) and the transcription factor nuclear factor-κB (NF-κB) significantly diminished the free radicals’ signal intensity, implicating these factors in the formation of free radicals. We have also demonstrated that cytokine treatment leads to the activation of NF-κB in the pancreatic islets of the rats.
- COX, cyclooxygenase
- EPR, electron paramagnetic resonance
- HBSS, Hank’s balanced salt solution
- IFN, interferon
- IL, interleukin
- NF-κB, nuclear factor-κB
- PBN, phenyl-N-tert-butylnitrone
- PDTC, Pyrrolidine dithiocarbamate
- PGE2, prostaglandin E2
- ROS, reactive oxygen species
- SOD, superoxide dismutase
- STZ, streptozotocin
- TNF-α, tumor necrosis factor-α
Footnotes
-
- Accepted April 21, 2003.
- Received January 7, 2003.
- DIABETES














